U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Sat Dec 16 18:56:43 GMT 2023
Edited
by admin
on Sat Dec 16 18:56:43 GMT 2023
Nucleic Acid Type siRNA
Nucleic Acid Subtype
Sequence Origin SYNTHETIC
Sequence Type OLIGONUCLEOTIDE
Record UNII
UPC6BTX7PY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INCLISIRAN SODIUM
USAN   INN  
Common Name English
RNA, (AM-SP-(2'-DEOXY-2'-FLUORO)C-SP-AM-(2'-DEOXY-2'-FLUORO)A-(2'-DEOXY-2'-FLUORO)A-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)C-AM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)A-CM-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)G-UM-(2'-DEOXY-2'-FLUORO)
Systematic Name English
LEQVIO SODIUM
Brand Name English
ALN-PCSSC SODIUM
Code English
Inclisiran sodium [WHO-DD]
Common Name English
ALN-60212 SODIUM
Code English
INCLISIRAN SODIUM [JAN]
Common Name English
Code System Code Type Description
SMS_ID
300000013624
Created by admin on Sat Dec 16 18:56:43 GMT 2023 , Edited by admin on Sat Dec 16 18:56:43 GMT 2023
PRIMARY
RXCUI
2588259
Created by admin on Sat Dec 16 18:56:43 GMT 2023 , Edited by admin on Sat Dec 16 18:56:43 GMT 2023
PRIMARY
DAILYMED
UPC6BTX7PY
Created by admin on Sat Dec 16 18:56:43 GMT 2023 , Edited by admin on Sat Dec 16 18:56:43 GMT 2023
PRIMARY
CAS
1639324-62-1
Created by admin on Sat Dec 16 18:56:43 GMT 2023 , Edited by admin on Sat Dec 16 18:56:43 GMT 2023
PRIMARY
FDA UNII
UPC6BTX7PY
Created by admin on Sat Dec 16 18:56:43 GMT 2023 , Edited by admin on Sat Dec 16 18:56:43 GMT 2023
PRIMARY
Sugar Site Range Site Count
Deoxyribose (DNA) 1_11 1 / 45
2'-Fluoro-Ribose 1_7;1_9;2_2;2_4-2_6;2_8;2_10;2_12;2_14;2_16;2_18 12 / 45
2'-O-Methyl-Ribose 1_1-1_6;1_8;1_10;1_12-1_22;2_1;2_3;2_7;2_9;2_11;2_13;2_15;2_17;2_19-2_23 32 / 45
Linkage Site Range Site Count
Sodium Phosporothioate 1_2-1_3;2_2-2_3;2_22-2_23 6 / 43
1_1;1_4-1_21;2_1;2_4-2_20 37 / 43
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOTIDE SUBSTITUTION [1_22] SITE_SPECIFIC U GIVOSIRAN SODIUM TRIGLYCAN-END GROUP 8142CN1H73
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUNENCE(CALCULATED) CHEMICAL